Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05730543 · ClinicalTrials.gov registry record · Phase 3
Ethnic Lip Augmentation With Hyaluronic Acid Filler
A Phase 3 study, sponsored by DeNova Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT05730543 is a Phase 3 study that has completed, run by DeNova Research. The registered enrollment target is 20 participants.
The verdict
NCT05730543, a Phase 3 study, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
Lip augmentation using hyaluronic acid filler in females with Fitzpatrick skin type V-VI
Interventions
- DRUG Volbella or Juvederm Ultra XC filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2023-07-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05730543
The ClinicalTrials.gov registry entry for NCT05730543 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Volbella or Juvederm Ultra XC filler is the first listed.
NCT05730543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05730543 about?
NCT05730543 is a clinical study titled "Ethnic Lip Augmentation With Hyaluronic Acid Filler". Lip augmentation using hyaluronic acid filler in females with Fitzpatrick skin type V-VI
What is the current status of trial NCT05730543?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2022-11-01. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT05730543?
The interventions under investigation include: Volbella or Juvederm Ultra XC filler (DRUG).
Who is sponsoring clinical trial NCT05730543?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.